1. Cook, RJ, Gladman, DD, Pericak, D, et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000; 27: 1892–1895.
Google Scholar | Medline | ISI2. Urowitz, MB, Gladman, DD, Tom, BDM, et al. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 2152–2158.
Google Scholar | Crossref | Medline | ISI3. Mosca, M, Tani, C, Aringer, M, et al. European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010; 69: 1269–1274.
Google Scholar | Crossref | Medline | ISI4. Ceccarelli, F, Perricone, C, Massaro, L, et al. Assessment of disease activity in systemic lupus erythematosus: lights and shadows. Autoimmun Rev 2015; 14: 601–608. DOI: 10.1016/j.autrev.2015.02.008.
Google Scholar | Crossref | Medline5. Liang, MH., Socher, SA, Larson, MG, et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107–1118.
Google Scholar | Crossref | Medline6. Symmons, DP, Coppock, JS, Bacon, PA, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med 1988; 69: 927–937.
Google Scholar | Medline7. Bombardier, C, Gladman, DD, Urowitz, MB, et al. Derivation of the sledai. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.
Google Scholar | Crossref | Medline8. Gladman, DD, Ibañez, D, Urowitz, MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatology 2002; 29: 288–291.
Google Scholar | Medline | ISI9. Vitali, C, Bencivelli, W, Isenberg, DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541–547.
Google Scholar | Medline | ISI10. Karlson, EW, Daltroy, LH, Rivest, C, et al. Validation of a systemic lupus activity questionnaire (SLAQ) for population studies. Lupus 2003; 12: 280–286.
Google Scholar | SAGE Journals | ISI11. Yazdany, J, Yelin, EH, Panopalis, P, et al. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 2008; 59: 136–143. DOI: 10.1002/art.23238.
Google Scholar | Crossref | Medline12. Flower, CH, Hennis, AJM, Liang, MH. Report of an international symposium on narrowing the gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments. Curr Rev Musculoskelet Med 2011; 4: 105–112. DOI: 10.1007/s12178-011-9080-0.
Google Scholar | Crossref | Medline13. Chehab, G, Richter, J, Sander, O, et al. Validation and evaluation of the German version of the systemic lupus activity questionnaire (SLAQ). Clin Exp Rheumatol 2015; 33: 354–359.
Google Scholar | Medline | ISI14. Okamoto, Y, Katsumata, Y, Baba, S, et al. Validation of the Japanese version of the systemic lupus activity questionnaire that includes physician-based assessments in a large observational cohort. Lupus 2016; 25: 486–495. DOI: 10.1177/0961203315617844.
Google Scholar | SAGE Journals | ISI15. Pettersson, S, Svenungsson, E, Gustafsson, J, et al. A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the systemic lupus activity questionnaire. Scand J Rheumatol 2017; 46: 474–483. DOI: 10.1080/03009742.2016.1276959.
Google Scholar | Crossref | Medline16. Tani, C, Vagelli, R, Stagnaro, C, et al. Translation, cultural adaptation and validation of the systemic lupus erythematosus activity questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients. Lupus 2018; 27: 1735–1741. DOI: 10.1177/0961203318785772.
Google Scholar | SAGE Journals | ISI17. Pons-Estel, BA, Catoggio, LJ, Cardiel, MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Medicine 2004; 83: 1–17.
Google Scholar | Crossref | Medline | ISI18. Graffar, M . Une methode de classification sociale d'échantillon des populations sample. Courrier 1956; 445–459.
Google Scholar19. Beaton, DE, Bombardier, C, Guillemin, F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000; 25: 3186–3191. DOI: 10.1097/00007632-200012150-00014.
Google Scholar | Crossref | Medline | ISI20. McElhone, K, Abbott, J, Shelmerdine, J, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 972–979.
Google Scholar | Crossref | Medline21. Machado Escobar, MA, Yacuzzi, MS, Martinez, RN, et al. Validation of an Argentine version of lupus quality of life questionnaire. Lupus 2016; 25: 1615–1622.
Google Scholar | SAGE Journals | ISI22. Karlson, EW, Daltroy, LH, Lew, RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 47–56.
Google Scholar | Crossref | Medline23. Petri, M, Buyon, J, Kim, M. Classification and definition of major flares in SLE clinical trials. Lupus 1999; 8: 685–691.
Google Scholar | SAGE Journals | ISI24. Buyon, JP, Petri, MA, Kim, MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005; 142: 953–962.
Google Scholar | Crossref | Medline | ISI